NIH #5R44NS124398-03
Preclinical development of a novel therapeutic for Parkinson's disease
- Amount
- $1.3M
- Period
- 2021-09-30 → 2025-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #3R44NS124398-02S1
Preclinical development of a novel therapeutic for Parkinson's disease
- Amount
- $100K
- Period
- 2023-09-01 → 2025-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #4R44NS124398-02
Preclinical development of a novel therapeutic for Parkinson's disease
- Amount
- $1.5M
- Period
- 2021-09-30 → 2025-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #5R44GM130268-03
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery
- Amount
- $872K
- Period
- 2018-09-01 → 2024-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #1R44NS124398-01
Preclinical development of a novel therapeutic for Parkinson's disease
- Amount
- $578K
- Period
- 2021-09-30 → 2023-02-28
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #2R44GM130268-02
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery
- Amount
- $1.3M
- Period
- 2018-09-01 → 2023-01-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #5R44GM121117-03
Developing a systems biology platform for predicting, preventing, and treating drug side effects
- Amount
- $754K
- Period
- 2016-09-15 → 2022-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #2R44GM121117-02
Developing a systems biology platform for predicting, preventing, and treating drug side effects
- Amount
- $803K
- Period
- 2016-09-15 → 2021-04-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #5R44HL127843-03
Improving safety and efficacy of platelet transfusion through systems biology
- Amount
- $429K
- Period
- 2015-08-01 → 2021-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #1R43HL146014-01A1
Improving safety and efficacy of platelet pathogen inactivation techniques through systems biology
- Amount
- $224K
- Period
- 2019-04-01 → 2020-09-30
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #1R43GM130268-01
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery
- Amount
- $442K
- Period
- 2018-09-01 → 2020-08-31
- PIs
- 2
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #5R44HL123074-03
Improving red blood cell transfusion through systems biology
- Amount
- $443K
- Period
- 2014-11-19 → 2019-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #2R44HL127843-02
Improving safety and efficacy of platelet transfusion through systems biology
- Amount
- $1.1M
- Period
- 2015-08-01 → 2019-03-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #2R44HL123074-02
Improving red blood cell transfusion through systems biology
- Amount
- $1.0M
- Period
- 2014-11-19 → 2018-05-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #1R43GM121117-01
Developing a Systems Biology Platform for Predicting Drug Toxicity and Safety
- Amount
- $191K
- Period
- 2016-09-15 → 2018-05-14
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #1R43HL127843-01A1
Improving safety and efficacy of platelet transfusion through systems biology
- Amount
- $224K
- Period
- 2015-08-01 → 2017-07-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.
NIH #1R43HL123074-01
Improving red blood cell transfusion through systems biology
- Amount
- $150K
- Period
- 2014-08-01 → 2016-01-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at SINOPIA BIOSCIENCES, INC.